GRI: GRI Bio Corp Earnings growth forecast for next year
GRI Bio, Inc. (GRI) business margins rely on the success of the GRI-0621 candidate and patent achievements in fibrosis treatment. The company's forward EPS dynamics model visualizes these expectations, where the 46.90 mark indicates the current state of earnings. The developer's authority is based on innovations in immunomodulation, while operational stability is ensured by strategic production outsourcing coupled with full control over intellectual property.
GRI (gribio.com): analytical breakdowns and indicator data
- price and consensus price forecast:
- market capitalization information:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples information:
GRI - Company Net Income|Future Profit GRI Bio, Inc.|GRI - Company Value to Net Income|Forward P/E Multiple GRI Bio, Inc.|GRI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GRI Bio|GRI - Operating profit before amortization|Net earnings per share (EPS TTM) GRI Bio|GRI - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months gribio.com|GRI - Expected net earnings per share growth this year|Earnings growth forecast for next year GRI Bio, Inc.
Fundamental company valuation:GRI Bio Corp, GRI
Investors are assessing the resilience of GRI Bio, Inc. (GRI) through the dynamics of earnings per share (EPS) revision trends, which capture the real-time rate of change in analyst consensus forecasts. By analyzing this EPS forecast chart, one can determine how the market values the commercial potential of immunotherapy and NKT-cell-based drugs, enabling the timely identification of a shift in the fundamental trend.
Key competitors
Net earnings per share growth forecast for next year Argenx|Projected earnings per share growth rate for next year BNTX (BioNTech Pharma)|Earnings growth forecast for next year ABVX|ADMA - Expected net earnings per share growth next year|Earnings growth forecast for next year PTGX (Protagonist)|Net earnings per one share growth forecast for next year Immunovant Inc|KNSA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year GRFS (Grifols Biemat)|ADPT: Earnings growth forecast for next year|CLDX - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year AUPH|BCRX: Expected earnings per share trend next year|Earnings growth forecast for next year VERA|Net earnings per share growth forecast for next year DNTH (Dianthus Corp)|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Consensus forecast of earnings per share growth for next year abcellera.com (ABCL)|TRML - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Precigen Inc|PHAR (Pharming) - Expected earnings per share growth for next year|Nektar Corp - Expected earnings per share trend next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Immunome (IMNM)|Gossamer Bio Inc - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|SEPN - Expected earnings per share growth for next year|PVLA: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year savarapharma.com SVRA|RIGL: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year AnaptysBio Inc ANAB|Net earnings per share growth forecast for next year Astria Pharma|ENGN: Expected earnings per share trend next year|Earnings growth forecast for next year RAPT|Consensus forecast of earnings per share growth for next year aerovatetx.com|Net earnings per share growth forecast for next year Aclaris Therapeutics, Inc. ACRS|KYTX (Kyverna Therapeutics Inc.) - Net earnings per share change forecast for next year|Tiziana Life Sciences PLC - Earnings growth forecast for next year|Expected earnings per share trend next year CABA (Cabaletta Bio Inc)|VTYX: Earnings growth forecast for next year|theratech.com (THTX) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Avalo Therapeutics|ELDN: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|Expected earnings per share growth for next year Climb Bio, Inc CLYM|Earnings growth forecast for next year ZURA (Zura Bio Limited)|Earnings growth forecast for next year atyrpharma.com ATYR|ADAG: Expected earnings per share growth for next year|Expected earnings per share trend next year IMA (ImageneBio Inc)|STTK: Earnings growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Expected earnings per share growth for next year Immunic Inc (IMUX)|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|Expected earnings per share growth for next year inflarx.de IFRX|X4 Pharma - Expected earnings per share growth for next year|Earnings growth forecast for next year Adicet Bio Inc. ACET|CELU - Net earnings per share growth forecast for next year|INMB (inmunebio.com) - Projected earnings per share growth rate for next year|BRNS: Earnings growth forecast for next year|Expected net earnings per share growth next year Kezar Life Sciences Inc. (KZR)|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|AKTX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year GOVX (GeoVax)|Consensus forecast of earnings per share growth for next year Edesa Biotech Inc (EDSA)|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (Carisma Therapeutics)|XTLB: Earnings growth forecast for next year|BOLT (Bolt Biotherapeutics, Inc.) - Net earnings per share growth forecast for next year|HCWB (HCW Biologics, Inc.) - Earnings growth forecast for next year|Aptevo (APVO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year AIM ImmunoTech (AIM)|ADTX - Expected net earnings per share growth next year|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year HIND|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Indaptus Therapeutics Inc INDP|Scinai (SCNI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CALI|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected earnings per share growth for next year Allakos Therapeutics (ALLK)|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|Consensus forecast of earnings per share growth for next year igmbio.com|Earnings growth forecast for next year ITOS (iTeos)|Net earnings per one share growth forecast for next year Ocean Biomedical Corp|TCBP - Net earnings per share growth forecast for next year|Expected earnings per share trend next year THRD (thirdharmonicbio.com)
